Showing results (391-400 of 687) with videos related to

Sort By:
Pageof 69
Pancreas|April 11, 2022
Celiac Plexus Neurolysis Is Associated With Decreased Survival in Patients With Pancreatic Cancer: A Propensity Score AnalysisHaley M Zylberberg, Satish Nagula, Sheila D Rustgi, et al.
Cancer Cell|July 5, 2008
Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancerOlena Barbash, Petia Zamfirova, Douglas I Lin, et al.
Oncogene|May 30, 2006
Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1S Benzeno, F Lu, M Guo, et al.
Cancer Research|November 3, 2006
Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous RasSeok-Hyun Kim, Hiroshi Nakagawa, Arunasalam Navaraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2014
Evolution of physiological responses to salt stress in hexaploid wheatChunwu Yang, Long Zhao, Huakun Zhang, et al.
BMC Cancer|February 10, 2021
Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patientsKiwoon Baeg, Cynthia Harris, Monica S Naparst, et al.
World Journal of Gastrointestinal Endoscopy|February 22, 2019
Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in pancreatic cancerSheila D Rustgi, Sunil P Amin, Michelle K Kim, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 21, 2009
Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epitheliumTomoyuki Okumura, Sophie S W Wang, Shigeo Takaishi, et al.
Oncogene|October 7, 2004
Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancerPerry S Mongroo, Cameron N Johnstone, Izabela Naruszewicz, et al.
The American Journal of Gastroenterology|April 6, 2016
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Pageof 69